Cargando…
Comparative lipidomics of 5-Fluorouracil–sensitive and –resistant colorectal cancer cells reveals altered sphingomyelin and ceramide controlled by acid sphingomyelinase (SMPD1)
5-Fluorouracil (5-FU) is a chemotherapeutic drug widely used to treat colorectal cancer. 5-FU is known to gradually lose its efficacy in treating colorectal cancer following the acquisition of resistance. We investigated the mechanism of 5-FU resistance using comprehensive lipidomic approaches. We p...
Autores principales: | Jung, Jae Hun, Taniguchi, Kohei, Lee, Hyeong Min, Lee, Min Young, Bandu, Raju, Komura, Kazumasa, Lee, Kil Yeon, Akao, Yukihiro, Kim, Kwang Pyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145850/ https://www.ncbi.nlm.nih.gov/pubmed/32273521 http://dx.doi.org/10.1038/s41598-020-62823-0 |
Ejemplares similares
-
Ceramide/Sphingomyelin Rheostat Regulated by Sphingomyelin Synthases and Chronic Diseases in Murine Models
por: Taniguchi, Makoto, et al.
Publicado: (2020) -
Molecular basis for the catalytic mechanism of human neutral sphingomyelinases 1 (hSMPD2)
por: Yi, Jingbo, et al.
Publicado: (2023) -
Neutral sphingomyelinase (SMPD3) deficiency disrupts the Golgi secretory pathway and causes growth inhibition
por: Stoffel, Wilhelm, et al.
Publicado: (2016) -
Exosomes mediate Zika virus transmission through SMPD3 neutral Sphingomyelinase in cortical neurons
por: Zhou, Wenshuo, et al.
Publicado: (2019) -
mRNA Expression of SMPD1 Encoding Acid Sphingomyelinase Decreases upon Antidepressant Treatment
por: Rhein, Cosima, et al.
Publicado: (2021)